METHODS	Patients were eligible if a decision had been made to switch antiretroviral therapy , the most recent HIV-1 RNA plasma viral load ( VL ) exceeded 2000 copies/mL , and the clinician was unable to select a potent regimen of 3 or more drugs without access to a resistance test .\